The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Clinical trial NCT05440422 · RECRUITING
Trial details
- NCT number
- NCT05440422
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2027-08-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.